Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Neoplasms. Found 218 abstracts

no pagination
Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol. 2017 Jul;3(7):961-8.   PMCID: PMC5557289
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.
Alexander J, Cukierman E. Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions. Current opinion in cell biology. 2016 Oct;42:80-93.   PMCID: PMC5064819
Bober SL, Reese JB, Barbera L, Bradford A, Carpenter KM, Goldfarb S, Carter J. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Current opinion in supportive and palliative care. 2016 Mar;10(1):44-54.   PMCID: PMC4984532
Meropol NJ, Wong YN, Albrecht T, Manne S, Miller SM, Flamm AL, Benson AB, Buzaglo J, Collins M, Egleston B, Fleisher L, Katz M, Kinzy TG, Liu TM, Margevicius S, Miller DM, Poole D, Roach N, Ross E, Schluchter MD. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials. J Clin Oncol. 2016 Feb 10;34(5):469-78.   PMCID: PMC4872012
Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: US-Blacks, Haitians, and Jamaicans. Cancer control : journal of the Moffitt Cancer Center. 2016 Oct;23(4):347-58.   PMCID: PMC5321133
Wong YN, Schluchter MD, Albrecht TL, Benson AB, Buzaglo J, Collins M, Flamm AL, Fleisher L, Katz M, Kinzy TG, Liu TM, Manne S, Margevicius S, Miller DM, Miller SM, Poole D, Raivitch S, Roach N, Ross E, Meropol NJ. Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. J Clin Oncol. 2016 Feb 10;34(5):479-87.   PMCID: PMC4872013
Banydeen R, Rose AM, Martin D, Aiken W, Alexis C, Andall-Brereton G, Ashing K, Avery JG, Avery P, Deloumeaux J, Ekomaye N, Gabriel O, Hassell T, Hughes L, Hutton M, Jyoti SK, Layne P, Luce D, Patrick A, Prussia P, Smith-Ravin J, Veronique-Baudin J, Blackman E, Roach V, Ragin C. Advancing Cancer Control Through Research and Cancer Registry Collaborations in the Caribbean. Cancer control : journal of the Moffitt Cancer Center. 2015 Oct;22(4):520-30.   PMCID: 4743663
Bradbury AR, Patrick-Miller L, Long J, Powers J, Stopfer J, Forman A, Rybak C, Mattie K, Brandt A, Chambers R, Chung WK, Churpek J, Daly MB, Digiovanni L, Farengo-Clark D, Fetzer D, Ganschow P, Grana G, Gulden C, Hall M, Kohler L, Maxwell K, Merrill S, Montgomery S, Mueller R, Nielsen S, Olopade O, Rainey K, Seelaus C, Nathanson KL, Domchek SM. Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genetics in Medicine. 2015 Jun;17(6):485-92.   PMCID: 4983405
Culnan E, Kloss JD, Darlow S, Heckman CJ. Associations between seasonal sleep change and indoor tanning. Psychological Reports. 2015 Apr;116(2):523-33.
Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015 Dec;35 Suppl:S25-54.   PMCID: PMC4898971
Peethambaram PP, Hartmann LC, Jonker DJ, de Jonge M, Plummer ER, Martin L, Konner J, Marshall J, Goss GD, Teslenko V, Clemens PL, Cohen LJ, Ahlers CM, Alland L. A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors. Invest New Drugs. 2015 Apr;33(2):321-31.
Prudnikova TY, Rawat SJ, Chernoff J. Molecular Pathways: Targeting the Kinase Effectors of RHO-Family GTPases. Clinical Cancer Research. 2015 Jan;21(1):24-9.   PMCID: 4286478
Rapoport N, Gupta R, Kim YS, O'Neill BE. Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging. J Control Release. 2015 May 28;206:153-60.
Rixe O, Puzanov I, LoRusso PM, Cohen RB, Morris JC, Olowokure OO, Yin JY, Doroumian S, Shen L, Olszanski AJ. Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. Anti-Cancer Drugs. 2015 Aug;26(7):785-92.   PMCID: 4484664
Tong EK, Fagan P, Cooper L, Canto M, Carroll W, Foster-Bey J, Hebert JR, Lopez-Class M, Ma GX, Nez Henderson P, Perez-Stable EJ, Santos L, Smith JH, Tan Y, Tsoh J, Chu K. Working to Eliminate Cancer Health Disparities from Tobacco: A Review of the National Cancer Institute's Community Networks Program. Nicotine Tob Res. 2015 Aug;17(8):908-23.   PMCID: PMC4542844
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, Zhang D, Yuan H, Hua K, Lu Y, Katsaros D, Huang Q, Montone K, Fan Y, Coukos G, Boyd J, Sood AK, Rebbeck T, Mills GB, Dang CV, Zhang L. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 2015 Oct 12;28(4):529-40.   PMCID: 4777353
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, Zhang D, Yuan H, Hua K, Lu Y, Katsaros D, Huang Q, Montone K, Fan Y, Coukos G, Boyd J, Sood AK, Rebbeck T, Mills GB, Dang CV, Zhang L. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 2015 Oct 12;28(4):529-40.
Brana I, Berger R, Golan T, Haluska P, Edenfield J, Fiorica J, Stephenson J, Martin LP, Westin S, Hanjani P, Jones MB, Almhanna K, Wenham RM, Sullivan DM, Dalton WS, Gunchenko A, Cheng JD, Siu LL, Gray JE. A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours. Br J Cancer. 2014 Nov 11;111(10):1932-44.   PMCID: Pmc4229637
Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, Bruner DW, Movsas B. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. Journal of the National Cancer Institute. 2014 Jul;106(7).   PMCID: 4192043
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Neoplasms

Neoplasms Female methods therapy Male genetics pathology Aged drug therapy epidemiology United States therapeutic use Middle Aged pharmacokinetics Patient Education as Topic Clinical Trials as Topic Tumor Cell Line metabolism Antineoplastic Agents administration & dosage National Cancer Institute (US) antagonists & inhibitors Adult psychology Monoclonal Antibodies Maximum Tolerated Dose Decision Making prevention & control Surveys and Questionnaires adverse effects Prognosis Gene Expression Profiling Follow-Up Studies Genetic Variation Cohort Studies Antineoplastic Combined Chemotherapy Protocols Long Noncoding RNA etiology diagnosis analogs & derivatives Human Genome Genetic Epigenesis complications Signal Transduction Genetic Transcription trends Drug Dose-Response Relationship Neoplastic Gene Expression Regulation Molecular Targeted Therapy Computational Biology Internet Trismus Neoplastic Stem Cells Workaholism Melanoma Conflict (Psychology) Fatigue Glucocorticoids Extracellular Matrix Head and Neck Questionnaires Dextroamphetamine rho GTP-Binding Proteins Haiti Communication Drug Delivery Systems Optical Imaging 80 and over Aged Health Communication Fibroblasts Reproductive Health Carcinogenesis Self Efficacy IGF Type 1 Receptor Nanoparticle extravasation Nivolumab Sialorrhea Genetic Heterogeneity mortality Physiological Processes [2540] CTLA-4 Antigen Attitudes Health Knowledge-Practice Half-Life Taxoids Incidence Propionates Registries Nude Mice Survivors Phosphotransferases Biological Models Intravital microscopy Randomized Controlled Trials as Topic Hoarseness Paclitaxel Prospective Studies Decision Support Techniques Nanoparticles Treatment Outcome biosynthesis Drug Carriers drug effects adverse Health Status Disparities physiopathology Nanodroplets TOR Serine-Threonine Kinases Phase III Clinical Trials as Topic Polymers Nanoparticle diffusion Thyroiditis Cell Cycle Proteins Cooperative Behavior Deglutition Disorders Perfluorocarbon effects Sulfones Drug delivery Early Intervention (Education) Case-Control Studies Phytogenic Antineoplastic Agents Genetic Counseling Therapeutic targets Patient Participation Cancer-Associated Fibroblasts ethics Women's Health Serotonin Uptake Inhibitors Physiological Sexual Dysfunction Sleep Methylphenidate Natural products indoor tanning sleep-skin cancer-risk factors Cancer stem cells economics chemically induced Wakefulness-Promoting Agents Quality of Life Ipilimumab Paroxetine CD274 Antigens Microscopy Self Report Central Nervous System Stimulants Genetic Predisposition to Disease Dexmethylphenidate Hydrochloride Risk Factors Benzhydryl Compounds Monoclonal Antibodies-Humanized Psychotherapy
Last updated on Tuesday, October 10, 2017